Raltitrexed Tomudex

Raltitrexed Tomudex

This chemotherapy and cancer drugs article is about Raltitrexed (Tomudex) which is a chemotherapy drug used to treat bowel cancer. It is one of a group of drugs known as the anti-metabolites. These are similar to some normal body molecules, but they are slightly different in structure.  They stop cells making and repairing DNA.  Cancer cells need to make and repair DNA so they can grow and multiply.  Anti-metabolites also stop normal cells working properly which is why they cause side effects.

Research done by the Cancer Care Ontario has shown that data on toxicity from one of the randomized controlled trials indicate lower rates of leukopenia and stomatitis for raltitrexed compared with 5 fluorouracil (5-FU), which is the more standard treatment and thus may be useful for older or frailer patients. Raltitrexed is taken intravenously

Side effects can include: fatigue, nausea, diarrhoea, increased risk of infection, mouth ulcers, loss of appetite, temporary liver changes, possible loss of fertility, hair loss, constipation.

Approved by

the Medical Board. 

Click Here

 

 

 

 

 

 

Other articles that you may find interesting are:

  1. A diet for Chemotherapy
  2. Immunotherapy overview
  3. A to Z Guide to Complementary Therapies

Go to: Return to the CANCERactive drug list

 

Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.